CCS
ACLS icon

Crosspoint Capital Strategies’s Axcelis ACLS Stock Holding History

Crosspoint Capital Strategies’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,500
Closed -$13K – 501
2014
Q1 		$13K Buy
+1,500
New +$13.8K 0.01% 432

Other funds holding ACLS

DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Schneider Capital Management Berwyn, Pennsylvania $175M AUM 42.51% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Crosspoint Capital Strategies's ACLS Position: Q2 2014 in Review

Crosspoint Capital Strategies sold out of Axcelis (ACLS) in Q2 2014, closing a stake of 1,500 shares — an estimated $13K sold.

Crosspoint Capital Strategies first reported a position in ACLS in Q1 2014 and held it in 1 quarter. The position peaked at $13K in Q1 2014. 94 funds tracked by Wall St. Rank hold ACLS as of Q2 2014.

  • Crosspoint Capital Strategies reported no remaining Axcelis position as of Q2 2014 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 1,500 Axcelis shares in Q2 2014, an estimated $13K.
  • Crosspoint Capital Strategies first reported a position in Axcelis in Q1 2014 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Axcelis position peaked at $13K in Q1 2014.
  • 94 funds tracked by Wall St. Rank held Axcelis as of Q2 2014.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2014, filed 29 Jul 2014.